Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
|1. ||Oral ranitidine: A promising novel therapeutic option in molluscum contagiosum in children|
|2. ||Real-life efficacy and safety of secukinumab : Single centre, retrospective observational study with 52 weeks follow up|
|3. ||A comparative study between topical adapalene (0.1%) vs combination of topical adapalene (0.1%) and intense pulsed light (ipl) therapy in treatment of inflammatorory and non inflammatory facial acne vulgaris: A split face randomized controlled trial|
|1. ||RARE TOXICITY WITH OXALIPLATIN – STEVEN JOHNSON SYNDROME|
|2. ||Sorafenib induced cutaneous toxicities: Four different presentations|
|2. ||Janus kinase inhibitors in Dermatology|